Skip to main content

Day: February 25, 2026

QNB Corp. and The Victory Bancorp, Inc. Announce Regulatory Approvals Received for Merger

Quakertown, PA and Limerick, PA, Feb. 25, 2026 (GLOBE NEWSWIRE) — QNB Corp. (“QNB” or the “Company”) (OTCQX: QNBC), the holding company for QNB Bank, and The Victory Bancorp, Inc. (“Victory”) (OTCQX: VTYB), the holding company for The Victory Bank, today jointly announced that they have received all required regulatory approvals to complete their previously announced merger transaction (the “Merger”). The transaction, initially announced on September 23, 2025, is expected to close during the second quarter, subject to the satisfaction of customary closing conditions. About QNB Corp. QNB Corp. is the holding company for QNB Bank, which is headquartered in Quakertown, Pennsylvania. QNB Bank currently operates twelve branches in Bucks, Lehigh, and Montgomery Counties and offers commercial and retail...

Continue reading

Toll Brothers Announces Final Opportunity to Own a Luxury Home at Woodcrest Hills in Simpsonville, South Carolina

Limited homes remain available in this sought-after Five Forks community SIMPSONVILLE, S.C., Feb. 25, 2026 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the final opportunity for home shoppers to purchase a new luxury home at Woodcrest Hills, a boutique community located in Simpsonville, South Carolina. Only four new homes remain available for sale in this serene Five Forks enclave.Woodcrest Hills is offering the final selection of quick move-in homes priced from the low $400,000s with move-in dates as early as April 2026. Nestled in an idyllic and natural setting, the community features wooded home sites, open floor plans, and well-appointed kitchens designed to fit every lifestyle.“Woodcrest Hills offers home shoppers a unique combination of sophisticated...

Continue reading

Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution

DESMODA is the first and only FDA-approved desmopressin oral solution Commercial launch expected on March 9th DESMODA eliminates tablet splitting and crushing, enabling precise, individualized dosing for patients of all ages The product is expected to be a significant long-term growth contributor, with potential peak sales of $30-50 million annually and patent protection extending through 2044DEER PARK, Ill., Feb. 25, 2026 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced the U.S. Food and Drug Administration (FDA) approval of a New Drug Application (NDA) for DESMODA™ (desmopressin acetate) Oral Solution for the management of central diabetes insipidus, also...

Continue reading

T3 Defense Inc. Announces Private Placement of up to $20 Million to Accelerate Acquisition Strategy

Two-tranche financing strengthens balance sheet and supports disciplined expansion across defense industrial base NEW YORK and TEL AVIV, Israel, Feb. 25, 2026 (GLOBE NEWSWIRE) — T3 Defense Inc. (NASDAQ: DFNS), formerly Nukkleus Inc., today announced that it has entered into definitive agreements for a committed private investment for up to $20 million from Esousa Group Holdings, LLC, a New York-based family office and an existing shareholder. The financing is intended to accelerate the company’s disciplined roll-up strategy, consolidating and scaling high-value suppliers operating at structurally constrained points within the defense industrial base. The financing is structured in two tranches, with $10 million funded at closing and a second $10 million tranche committed, subject to an effective registration statement covering...

Continue reading

Danone: Notification of availability of Danone’s 2025 consolidated financial statements and statutory auditors’ report

Press Release – Paris, February 25, 2026, at 7pm CET Notification of availability of Danone’s 2025 consolidated financial statements and statutory auditors’ report Danone announces that its consolidated financial statements and the statutory auditors’ report for the fiscal year ended December 31, 2025 are publicly available and accessible online on its website, www.danone.com, section Investors / Financial and extra-financial reports. About Danone (www.danone.com)  Danone is a leading global food and beverage company operating in three health-focused, fast-growing and on-trend Categories: Essential Dairy & Plant-Based products, Waters and Specialized Nutrition. With a long-standing mission of bringing health through food to as many people as possible, Danone aims to inspire healthier and more sustainable eating and drinking practices...

Continue reading

AMG Critical Materials N.V. Announces Strategic Acquisition of AURA Technologie to Establish First Circular High-Purity Molybdenum Platform

Amsterdam, 25 February 2026 — AMG Critical Materials N.V. (“AMG”, EURONEXT AMSTERDAM: “AMG”) acquired AURA Technologie GmbH in Germany for €10 million in a transaction consisting of 34% cash and 66% AMG shares. The acquisition represents a major strategic step in AMG’s expansion into high-purity molybdenum and strengthens its position in circular critical materials processing. AURA is an established processor of spent hydrodesulfurization (HDS) catalysts, which contain molybdenum as a key active component. The transaction provides AMG with an operational platform and experienced team, accelerating the commercialization of AMG’s proprietary molybdenum refining technology. “This acquisition marks the launch of AMG’s circular high-purity molybdenum business,” said Michael Connor, AMG’s Chief Corporate Development Officer. “We plan to...

Continue reading

Ilkka Oyj: Acquisition of own shares on 25 February 2026

Ilkka Oyj, Stock Exchange Release, 25 February 2026 at 07:00 p.m. EET Ilkka Oyj: Acquisition of own shares on 25 February 2026Date 25 February 2026  Exchange transaction Buy  Share trading code ILKKA2 FH  Amount, shares 1,547  Average price/share (EUR) 4.2548  Total cost (EUR) 6,582.18  After the acquisitions Ilkka Oyj holds a total of  91,855 treasury shares. On behalf of Ilkka Oyj Danske Bank A/S, Finland Branch Antti Väliaho                       Jonathan Nyberg For more information, please contact:Seija Peitso, CFO, Ilkka Oyjseija.peitso@ilkka.com Ilkka Oyj company descriptionAttachmentILKKA2.HE_20260225

Continue reading

WORLDLINE : FY2025 results : Press release

FY2025 in line with guidance Operational turnaround and transformation on track FY 2025 results, including MeTS:€4.5B Group revenue1, -2.4% organically vs 2024 (guidance of low single digit percentage decline) €841M adjusted EBITDA1, 18.7% adj EBITDA margin (guidance at €830m to €855m) €(9)M free cash flow12 (guidance at €-30M to €0M+) with €(49)M in H2 2025 Net result at €(5,157)M Group Share including €(4,647)M impairments of goodwill Normalised net results at €175MExcluding MeTS (under IFRS53) revenues, adjusted EBITDA and free cash flow respectively amount to €4.0B, €737M and €(26)M Turnaround and transformation on trackImproved churn in all geographies and improved order intake and pipeline in financial services in Q4 2025 Transformation initiatives operationalized with benefits in Q4 2025 and clear milestones for 2026 Pruning...

Continue reading

AMG Reports a Solid Set of Full Year 2025 Results

Amsterdam, 25 February 2026 (Regulated Information) — AMG Critical Materials N.V. (“AMG”, EURONEXT AMSTERDAM: “AMG”) reports full year adjusted EBITDA of $235 million in 2025, a 40% increase compared to the 2024 adjusted EBITDA of $168 million, driven primarily by our Antimony and Engineering businesses. We ended the year with a strong balance sheet highlighted by our $484 million of total liquidity as of December 31, 2025. Dr. Heinz Schimmelbusch, Chairman of the Management Board and CEO, said, “In 2025, we achieved the third highest adjusted EBITDA in the Company’s history despite weakness in lithium and vanadium. This flexible response to a changing market environment highlights the quality and the breadth of our critical materials and technologies portfolio. Governments are pushing for onshoring of critical materials supply,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.